The U.S. market for vascular access devices and accessories reached a valuation of $5.2 billion in 2022. The market is anticipated to increase at a CAGR of 2.5% to reach a value of $6.2 billion during the forecast period.
The comprehensive report suite covering the U.S. market for vascular access devices and accessories includes a wide range of products, such as implantable ports, port needles, central venous catheters (CVCs), peripherally inserted central catheters (PICCs), peripheral intravenous catheters (PIVCs), midlines, extended dwell catheters (EDCs), dialysis catheters, ultrasound machines specialized for vascular access, vein visualization devices, tip-placement devices, catheter securement devices, antibacterial catheter patches, catheter caps, syringes, and needles.
DATA TYPES INCLUDED:
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- Vascular Access Procedure Volumes
- Market Forecasts Until 2029, and Historical Data to 2019
- Competitive Analysis with Market Shares for Each Segment
- Market Drivers & Limiters for Each Vascular Access Device market
- Recent Mergers & Acquisitions
- COVID-19 Impact on the US Vascular Access and Accessories market
- Disease Overviews and Demographic Information
- Company Profiles, Product Portfolios, and SWOT for Top Competitors
U.S. VASCULAR ACCESS MARKET INSIGHTS
As a result of the complications and concerns linked to PICCs, the market is shifting towards more cost-effective catheter devices with lower failure rates. Two alternatives that are gaining popularity are midlines and extended dwell catheters, which are shorter and can be placed in peripheral veins to minimize the risk of infection and complications. Innovative technologies have been developed to enhance the dwell time and decrease failure rates of PIVCs, potentially reducing the number of catheters needed per patient. These advancements incorporate antimicrobial coatings, improved catheter materials, and enhanced insertion techniques.
U.S. VASCULAR ACCESS MARKET SHARE INSIGHT
Becton Dickinson, 3M, and Teleflex currently dominate the U.S. vascular access device market. However, the market has been shifting towards less expensive catheter devices with lower failure rates due to the complications and concerns associated with PICCs. Midlines and extended dwell catheters have emerged as popular alternatives that are gaining traction as they are shorter and can be placed in peripheral veins to reduce the risk of infection and complications. New technologies, such as antimicrobial coatings, better catheter materials, and improved insertion techniques, have been developed to improve the dwell time and reduce failure rates of PIVCs, resulting in fewer catheters being required per patient.
MARKET SEGMENTATION SUMMARY
- Implantable Port Market - MedCore
- Port Needle Market - MedCore
- Central Venous Catheter Market - MedCore
- Peripherally Inserted Central Catheter Market - MedCore
- Peripheral Intravenous Catheter Market - MedCore
- Midline Market - MedCore
- Extended Dwell Catheter Market - MedCore
- Dialysis Catheter Market - MedCore
- Vascular Access Ultrasound Market - MedCore
- Vein Visualization Device Market - MedCore
- Tip-placement Device Market - MedCore
- Catheter Securement Device Market - MedCore
- Antibacterial Catheter Patch Market - MedCore
- Catheter Cap Market - MedCore
- Syringe and Needle Market - MedCore
RESEARCH SCOPE SUMMARY
- Regions: North America (United States)
- Base Year: 2022
- Forecast Period: 2023-2029
- Historical Data: 2019-2022
- Quantitative Data: Market Size, Market Share, Market Growth Rates, Units Sold, Average Selling Prices
- Qualitative Data: COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios
- Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data.
WHY CHOOSE IDATA?
- Experts Only - iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
- Global Coverage - iData's unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
- Attention to Detail - It's our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.
- Pricing - When comparing like-with-like, iData's prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.